Dear customers,

we have started to provide the documents for our products in an electronic format. These are the Instructions for Use (IFU), the Safety Data Sheets (SDS) and the Certificate of Analysis (CoA). For batches placed on the market after 01 January 2023, you can find our documents on the eIFU portal https://eifu.r-biopharm.com.

RIDA®GENE Coronavirus

Intended use:For in vitro diagnostic use. The RIDA®GENE Coronavirus Test performed on the LightCycler® 480 II real-time PCR instrument is a multiplex real-time RT-PCR for the direct qualitative [...]

RIDA®GENE HLA-B27

Intended use:For in vitro diagnostic use. With the RIDA®GENE HLA-B27 kit HLA-B27 alleles in genomic DNA, isolated from human whole blood EDTA samples, are qualitatively detected by using [...]

RIDA®GENE Factor II

Intended use:For in vitro diagnostic use. The RIDA®GENE Factor II kit uses real-time PCR to qualitatively detect a point mutation of G to A at position 20210 in the human factor II (prothrombin) [...]

RIDA®GENE Factor V

By

Intended use:For in vitro diagnostic use. The RIDA®GENE Factor V kit uses real-time PCR to qualitatively detect a point mutation of G to A at position 1691 in the human factor V gene (Factor V [...]

RIDA®GENE Lac Intol

By

Intended use:For in-vitro diagnostic use. The RIDA®GENE Lac Intol test, which is performed on the LightCycler® 480 II, is a multiplex real-time PCR for the qualitative detection and [...]

page  5  of  9